AD risk alleles are specifically enriched in active enhancers of myeloid-derived cells that express PILRA such as monocytes, macrophages, and microglia, with PILRA expression contributing a systemic failure of cell-mediated amyloid-β (Aβ) clearance51, which likely contributes to AD onset and progression. The gene discussed is PILRA; the disease is Alzheimer disease.